Seattle, WA, United States of America

Erik Procko

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Erik Procko

Introduction

Erik Procko is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for diseases related to the Epstein-Barr virus.

Latest Patents

Procko holds a patent for "Polypeptides to inhibit Epstein Barr viral protein BHRF1 and B cell lymphoma family proteins." This invention provides designed polypeptides that selectively bind to and inhibit the Epstein-Barr protein BHRF1, as well as B cell lymphoma family proteins. These polypeptides are useful for treating Epstein-Barr-related diseases and cancer.

Career Highlights

Erik Procko is affiliated with the University of Washington, where he conducts research and develops innovative solutions in the field of molecular biology. His work has garnered attention for its potential impact on cancer treatment and viral infections.

Collaborations

Procko collaborates with esteemed colleagues, including David Baker and Geoffrey Y Berguig. Their combined expertise enhances the research efforts at the University of Washington.

Conclusion

Erik Procko's contributions to biotechnology and his innovative patent demonstrate his commitment to advancing medical science. His work holds promise for improving treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…